Xilio Therapeutics SG&A Expense (TTM) Trends

Xilio Therapeutics Inc (XLO)

1.14 +0.06 (+5.56%) USD | NASDAQ | May 17, 16:00

1.14 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
March 31, 2024	25.74M
December 31, 2023	27.00M
September 30, 2023	28.77M
June 30, 2023	29.63M
March 31, 2023	31.04M
December 31, 2022	29.95M

Date	Value
September 30, 2022	29.98M
June 30, 2022	28.30M
March 31, 2022	25.26M
December 31, 2021	23.86M
September 30, 2021	18.58M
June 30, 2021	16.25M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

16.25M

Minimum

Jun 2021

31.04M

Maximum

Mar 2023

26.20M

Average

27.65M

Median

SG&A Expense (TTM) Benchmarks